ANECTINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Anectine, and what generic alternatives are available?
Anectine is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in ANECTINE is succinylcholine chloride. There are six drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Anectine
A generic version of ANECTINE was approved as succinylcholine chloride by ZYDUS PHARMS on May 4th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANECTINE?
- What are the global sales for ANECTINE?
- What is Average Wholesale Price for ANECTINE?
Summary for ANECTINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Clinical Trials: | 1 |
Patent Applications: | 2,950 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ANECTINE |
What excipients (inactive ingredients) are in ANECTINE? | ANECTINE excipients list |
DailyMed Link: | ANECTINE at DailyMed |
![ANECTINE drug patent expirations Drug patent expirations by year for ANECTINE](/p/graph/s/t/ANECTINE-patent-expirations.png)
![Drug Prices for ANECTINE](/p/graph/drug-price/ANECTINE.png)
Recent Clinical Trials for ANECTINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University Hospital, Geneva | Phase 2 |
University of Lausanne Hospitals | Phase 2 |
Pharmacology for ANECTINE
Drug Class | Depolarizing Neuromuscular Blocker |
Physiological Effect | Neuromuscular Depolarizing Blockade |
US Patents and Regulatory Information for ANECTINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | ANECTINE | succinylcholine chloride | INJECTABLE;INJECTION | 008453-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | ANECTINE | succinylcholine chloride | INJECTABLE;INJECTION | 008453-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | ANECTINE | succinylcholine chloride | INJECTABLE;INJECTION | 008453-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Sandoz | ANECTINE | succinylcholine chloride | INJECTABLE;INJECTION | 008453-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |